Corynebacterium striatum meningitis: Case report and review of an increasingly important Corynebacterium species

Clinical Infectious Diseases

Volumn 23, Issue 6, 1996, Pages 1246-1248

  Weiss, K ^a   Labbe A C ^a   Laverdiere M ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CARBENICILLIN; CEFAZOLIN; CEFTAZIDIME; GENTAMICIN; MEZLOCILLIN; SULTAMICILLIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ACTINOMYCETALES; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CORYNEBACTERIUM STRIATUM; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION SENSITIVITY; MALE; MENINGITIS; PATHOGENICITY; PRIORITY JOURNAL; SKIN FLORA; SPECIES DIFFERENCE; TAXONOMY;

EID: 0030470662     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.6.1246     Document Type: Article

References (20)

1. Clarridge JE, Spiegel CA. Corynebacterium and miscellaneous irregular Gram-positive rods, Erysipelothrix, and Gardnerella. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:357-78.
2. Coyle MB, Lipsky BA. Coryneform bacteria in infectious diseases: clinical and laboratory aspects. Clin Microbiol Rev 1990; 3:227-46.
3. Dall L, Barnes WG, Hurford D. Septicaemia in a granulocytopenic patient caused by Corynebacterium striatum. Postgrad Med J 1989; 65:247-8.
4. Markowitz SM, Coudron PE. Native valve endocarditis caused by an organism resembling Corynebacterium striatum. J Clin Microbiol 1990; 28:8-10.
5. Watkins DA, Chahine A, Creger RJ, Jacobs MR, Lazarus HM. Corynebacterium striatum: a diphtheroid with pathogenic potential. Clin Infect Dis 1993; 17:21-5.
6. Tumbarello M, Tacconelli E, Del Forno A, Caponera S, Cauda R. Corynebacterium striatum bacteremia in a patient with AIDS [letter]. Clin Infect Dis 1994; 18:1007-8.
7. Rufael DW, Cohn SE. Native valve endocarditis due to Corynebacterium striatum: case report and review. Clin Infect Dis 1994; 19:1054-61.
8. Melero-Bascones M, Munoz P, Rodriguez-Creixems M, Bouza E. Corynebacterium striatum: an undescribed agent of pacemaker-related endocarditis [letter]. Clin Infect Dis 1996; 22:576-7.
9. Bowstead TT, Santiago SM. Pleuropulmonary infection due to Corynebacterium striatum. Br J Dis Chest 1980; 74:198-200.
10. Barr JG, Murphy PG. Corynebacterium striatum: an unusual organism isolated in pure culture from sputum [letter]. J Infect 1986; 13:297-8.
11. Cowling P, Hall L. Corynebacterium striatum: a clinically significant isolate from sputum in chronic obstructive airways disease [letter]. J Infect 1993; 26:335-6.
12. Martinez-Martinez L, Suarez AI, Ortega MC, Rodriguez-Jimenez R. Fatal pulmonary infection caused by Corynebacterium striatum [letter]. Clin Infect Dis 1994; 19:806-7.
13. Weiss K, Laverdière M, Rivest R. Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods. Antimicrob Agents Chemother 1996; 40:930-3.
14. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 3rd ed. NCCLS document M7-A3. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
15. Bhandari S, Meigh JA, Sellars L. CAPD peritonitis due to Corynebacterium striatum [letter]. Perit Dial Int 1995; 15:88-9.
16. Heidemann DG, Dunn SP, Diskin JA, Aiken TB. Corynebacterium striatum keratitis. Cornea 1991; 10:81-2.
17. Soriano F, Zapardiel J, Nieto E. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob Agents Chemother 1995; 39: 208-14.
18. Williams DY, Selepak ST, Gill VJ. Identification of clinical isolates of nondiphtherial Corynebacterium species and their antibiotic susceptibility patterns. Diagn Microbiol Infect Dis 1993; 17:23-8.
19. Schaad UB, Nelson JD, McCracken GH Jr. Pharmacology and efficacy of vancomycin for staphylococcal infections in children. Rev Infect Dis 1981; 3(suppl 1):S282-8.
20. Viladrich PF, Gudiol F, Linares J, et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991; 35:2467-72.